Cited by 2,480Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research

The DOI matches its Crossref record; 242 of the 245 references it cites were found in a registry or an index, and 1 are not checked yet.

Neurodegenerative Tauopathies

Lee, Virginia M-Y, Goedert, Michel, Trojanowski, John Q·2001·Annual Review of Neuroscience

DOI 10.1146/annurev.neuro.24.1.1121

Open this paper in CoChat — free account

Abstract

The defining neuropathological characteristics of Alzheimer's disease are abundant filamentous tau lesions and deposits of fibrillar amyloid beta peptides. Prominent filamentous tau inclusions and brain degeneration in the absence of beta-amyloid deposits are also hallmarks of neurodegenerative tauopathies exemplified by sporadic corticobasal degeneration, progressive supranuclear palsy, and Pick's disease, as well as by hereditary frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Because multiple tau gene mutations are pathogenic for FTDP-17 and tau polymorphisms appear to be genetic risk factors for sporadic progressive supranuclear palsy and corticobasal degeneration, tau abnormalities are linked directly to the etiology and pathogenesis of neurodegenerative disease. Indeed, emerging data support the hypothesis that different tau gene mutations are pathogenic because they impair tau functions, promote tau fibrillization, or perturb tau gene splicing, thereby leading to formation of biochemically and structurally distinct aggregates of tau. Nonetheless, different members of the same kindred often exhibit diverse FTDP-17 syndromes, which suggests that additional genetic or epigenetic factors influence the phenotypic manifestations of neurodegenerative tauopathies. Although these and other hypothetical mechanisms of neurodegenerative tauopathies remain to be tested and validated, transgenic models are increasingly available for this purpose, and they…

Integrity signals

Registry

Crossref · 10.1146/annurev.neuro.24.1.1121

Cites

242 of 243 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Prions
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Self-citation
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP International Workshop*
Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Self-citation

Show all 245 references

Research works printed but not linked: 19

Arrasate M, 1997, Am. J. Pathol., 151, 1115
Brion JP, 1985, Arch. Biol., 95, 229
Feany MB, 1995, Am. J. Pathol., 146, 1388
10.1007/s004010050296 · DOI
10.1128/mcb.9.4.1381 · DOI
Hong M, Trojanowski JQ, Lee VM-Y. 2000.Tau-based neurofibrillary lesions.InNeurodegenerative Dementias, ed. CM Clark, JQ Trojanowski, pp. 161–75. New York: McGraw Hill
10.1007/s004010050140 · DOI
Ksiezak-Reding H, 1994, Am. J. Pathol., 145, 1496
10.1007/s004010050138 · DOI
Pickering-Brown S, 2000, Ann. Neurol., 48, 806, 10.1002/1531-8249(200012)48:6<859::aid-ana6>3.0.co;2-1 · DOI
Rebeiz J, 1967, Trans. Am. Neurol. Assoc., 92, 23
Rep. Work Group Frontotemporal Dementia Pick's Disease. 2001. Clinical and neuropathological diagnosis of frontotemporal dementias.Neurobiol. Aging.In press
Shin RW, 1991, Lab. Invest., 64, 693
Snow AD, 1990, Am. J. Pathol., 137, 1253
10.1002/1531-8249(200012)48:6<939::aid-ana17>3.3.co;2-t · DOI
Trojanowski JQ, 1994, Am. J. Pathol., 144, 449
10.1007/s004010050126 · DOI
Wilhelmsen KC, 1994, Am. J. Hum. Genet., 55, 1159
Wilson DM, 1997, Am. J. Pathol., 150, 2181

Sorted by citations

Items 901–1,000 of 1,023

What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease?
Armstrong, R. A., Lantos, P. L., & Cairns, N. J. (2008) · Neuropathology · doi:10.1111/j.1440-1789.2008.00916.x · Cited by 57
Structural Basis of E2–25K/UBB+1 Interaction Leading to Proteasome Inhibition and Neurotoxicity
Ko, S., Kang, G. B., Song, S. M., Lee, J., Shin, D. Y., Yun, J.-H., Sheng, Y., Cheong, C., Jeon, Y. H., Jung, Y., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.145219 · Cited by 56
Tau hyperphosphorylation is associated with memory impairment after exposure to 1.5% isoflurane without temperature maintenance in rats
Tan, W., Cao, X., Wang, J., Huang-wei, L., Bin-yang, W., & Ma, H. (2010) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32833a6561 · Cited by 56
The ΔK280 Mutation in MAP tau Favors Exon 10 Skipping In Vivo
Swieten, J. C. V., Bronner, I. F., Azmani, A., Severijnen, L.-A. W. F. M., Kamphorst, W., Ravid, R., Rizzu, P., Willemsen, R., & Heutink, P. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31802c39a4 · Cited by 56
Yeast as a model for studying Alzheimer's disease
Bharadwaj, P., Martins, R. N., & Macreadie, I. G. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00658.x · Cited by 56
Brain-derived neurotrophic factor and TrkB expression in the “oldest-old,” the 90+ Study: correlation with cognitive status and levels of soluble amyloid-beta
Michalski, B., Corrada, M. M., Kawas, C. H., & Fahnestock, M. L. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.08.022 · Cited by 57
Attenuation of synaptic toxicity and MARK4/PAR1-mediated Tau phosphorylation by methylene blue for Alzheimer’s disease treatment
Sun, W., Lee, S., Huang, X., Liu, S., Inayathullah, M., Kim, K.-M., Tang, H., Ashford, J. W., & Rajadas, J. (2016) · Scientific Reports · doi:10.1038/srep34784 · Cited by 55
A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies
Giacomini, C., Koo, C.-Y., Yankova, N., Tavares, I. A., Wray, S., Noble, W. J., Hanger, D. P., & Morris, J. D. H. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0539-8 · Cited by 56
Tau is central in the genetic Alzheimer–frontotemporal dementia spectrum
Dermaut, B., Kumar‐Singh, S., Rademakers, R., Theuns, J., Cruts, M., & Broeckhoven, C. V. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.09.005 · Cited by 56
Tau induces cooperative Taxol binding to microtubules
Ross, J. L., Santangelo, C. D., Makrides, V., & Fygenson, D. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402928101 · Cited by 59
Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model
Helboe, L., Egebjerg, J., Barkholt, P., & Volbracht, C. (2017) · Brain Research · doi:10.1016/j.brainres.2017.04.002 · Cited by 56
Protein amyloid aggregate: Structure and function
Xu, Q., Ma, Y., Sun, Y., Li, D., Zhang, X., & Liu, C. (2023) · Aggregate · doi:10.1002/agt2.333 · Cited by 57
Evidence for RNA-Mediated Toxicity in the Fragile X-Associated Tremor/Ataxia Syndrome
Galloway, J. N., & Nelson, D. L. (2009) · Future Neurology · doi:10.2217/fnl.09.44 · Cited by 54
Luminescent Conjugated Oligothiophenes for Sensitive Fluorescent Assignment of Protein Inclusion Bodies
Klingstedt, T., Blechschmidt, C., Nogalska, A., Prokop, S., Häggqvist, B., Danielsson, O., Engel, W. K., Askanas, V., Heppner, F. L., & Nilsson, K. P. R. (2013) · ChemBioChem · doi:10.1002/cbic.201200731 · Cited by 55
P44, the ‘longevity‐assurance’ isoform of P53, regulates tau phosphorylation and is activated in an age‐dependent fashion
Pehar, M., Ko, M. H., Li, M., Scrable, H. J., & Puglielli, L. (2013) · Aging Cell · doi:10.1111/acel.12192 · Cited by 57
Plasma microRNA profiling distinguishes patients with frontotemporal dementia from healthy subjects
Grasso, M., Piscopo, P., Talarico, G., Ricci, L., Crestini, A., Tosto, G., Gasparini, M., Bruno, G., Denti, M. A., & Confaloni, A. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.01.024 · Cited by 54
Tau protein aggregates inhibit the protein-folding and vesicular trafficking arms of the cellular proteostasis network
Yu, A., Fox, S. G., Cavallini, A., Kerridge, C., O’Neill, M. J., Wolak, J., Bose, S., & Morimoto, R. I. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007527 · Cited by 55
A Physically-Modified Saline Suppresses Neuronal Apoptosis, Attenuates Tau Phosphorylation and Protects Memory in an Animal Model of Alzheimer's Disease
Modi, K. K., Jana, A., Ghosh, S., Watson, R. L., & Pahan, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103606 · Cited by 55
The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies
Hanger, D. P., Gibb, G., de Silva, R., Boutajangout, A., Brion, J., Révész, T., Lees, A. J., & Anderton, B. H. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03611-6 · Cited by 55
Cortical biochemistry in MCI and Alzheimer disease
Forman, M. S., Mufson, E. J., Leurgans, S. E., Praticò, D., Joyce, S. C., Leight, S., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Neurology · doi:10.1212/01.wnl.0000256373.39415.b1 · Cited by 54
Self-citation
Spinal Cord Neurofibrillary Pathology in Alzheimer Disease and Guam Parkinsonism-Dementia Complex
Schmidt, M. L., Zhukareva, V. A., Perl, D. P., Sheridan, S. K., Schuck, T., Lee, V. M. ‐., & Trojanowski, J. Q. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.11.1075 · Cited by 55
Self-citation
Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and α-synuclein pathology
Newman, J., Rissman, R. A., Sarsoza, F. M., Kim, R. C., Dick, M. B., Bennett, D. A., Cotman, C. W., Rohn, T. T., & Head, E. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1027-3 · Cited by 55
Quantification of Tau Protein Lysine Methylation in Aging and Alzheimer’s Disease
Huseby, C. J., Hoffman, C. N., Cooper, G. L., Cocuron, J.-C., Alonso, A. P., Thomas, S. N., Yang, A. J., & Kuret, J. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190604 · Cited by 54
Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer’s disease models: a systematic review and meta-analysis of preclinical studies
Kong, F., Wu, T., Dai, J., Zhai, Z., Cai, J., Zhu, Z., Xu, Y., & Sun, T. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1205207 · Cited by 54
The pattern of human tau phosphorylation is the result of priming and feedback events in primary hippocampal neurons
Bertrand, J., Plouffe, V., Sénéchal, P., & Leclerc, N. M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.009 · Cited by 57
Deleterious effects of soluble amyloid-β oligomers on multiple steps of synaptic vesicle trafficking
Park, J., Jang, M., & Chang, S. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.03.004 · Cited by 57
High-fat diet increases tau expression in the brain of T2DM and AD mice independently of peripheral metabolic status
Takalo, M., Haapasalo, A., Martiskainen, H., Kurkinen, K. M. A., Koivisto, H., Miettinen, P., Khandelwal, V. K. M., Kemppainen, S., Kamińska, D., Mäkinen, P. M., et al. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.02.003 · Cited by 55
Protein 600 Is a Microtubule/Endoplasmic Reticulum-Associated Protein in CNS Neurons
Shim, S. Y., Wang, J., Asada, N., Neumayer, G., Tran, H. C., Ishiguro, K., Sanada, K., Nakatani, Y., & Nguyen, M. D. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5278-07.2008 · Cited by 54
Tauopathy induced by low level expression of a human brain-derived tau fragment in mice is rescued by phenylbutyrate
Bondulich, M. K., Guo, T., Meehan, C., Manion, J., Martin, T. R., Mitchell, J. C., Hortobágyi, T., Yankova, N., Stygelbout, V., Brion, J., et al. (2016) · Brain · doi:10.1093/brain/aww137 · Cited by 52
Motifs in the tau protein that control binding to microtubules and aggregation determine pathological effects
Lathuilière, A., Valdés, P., Papin, S., Cacquevel, M., Maclachlan, C., Knott, G. W., Muhs, A., Paganetti, P., & Schneider, B. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-13786-2 · Cited by 57
Design principles and fundamental understanding of biosensors for amyloid-β detection
Zhang, Y., Ren, B., Zhang, D., Liu, Y., Zhang, M., Zhao, C., & Zheng, J. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00344a · Cited by 55
Mechanical injuries of neurons induce tau mislocalization to dendritic spines and tau-dependent synaptic dysfunction
Braun, N. J., Yao, K. R., Alford, P. W., & Liao, D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008306117 · Cited by 54
Presenilins in the Developing, Adult, and Aging Cerebral Cortex
Wines-Samuelson, M., & Shen, J. (2005) · The Neuroscientist · doi:10.1177/1073858405278922 · Cited by 54
Molecular mechanism of prion‐like tau‐induced neurodegeneration
Alonso, A. D., Beharry, C., Corbo, C. P., & Cohen, L. S. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.12.014 · Cited by 53
Systems biology of neurodegenerative diseases
Wood, L. B., Winslow, A. R., & Strasser, S. D. (2015) · Integrative Biology · doi:10.1039/c5ib00031a · Cited by 56
Early Growth Response 1 (Egr-1) Regulates Phosphorylation of Microtubule-associated Protein Tau in Mammalian Brain
Lu, Y., Li, T., Qureshi, H. Y., Han, D. C., & Paudel, H. K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.220962 · Cited by 54
Inhibitory Evaluation of Sulfonamide Chalcones on β-Secretase and Acylcholinesterase
Kang, J., Cho, J., Curtis-Long, M. J., Ryu, H., Kim, J. H., Kim, H. J., Yuk, H., Kim, D. W., & Park, K. (2012) · Molecules · doi:10.3390/molecules18010140 · Cited by 47
RETRACTED: Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3β pathway in ginsenoside Rb1's attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation
Zhao, R., Zhang, Z., Song, Y., Wang, D., Qi, J., & Wen, S. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.11.054 · Cited by 53
Retracted
Tauopathy models and human neuropathology: similarities and differences
Frank, S., Clavaguera, F., & Tolnay, M. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0291-9 · Cited by 59
Sustained Arginase 1 Expression Modulates Pathological Tau Deposits in a Mouse Model of Tauopathy
Hunt, J. B., Nash, K. R., Placides, D. S., Moran, P., Selenica, M. B., Abuqalbeen, F., Ratnasamy, K., Slouha, N., Ospina, S. R., Savlia, M., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3959-14.2015 · Cited by 57
GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils
Gibbons, G. S., Banks, R. A., Kim, B., Xu, H., Changolkar, L., Leight, S. N., Riddle, D. M., Li, C., Gathagan, R. J., Brown, H. J., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2393-17.2017 · Cited by 53
Self-citation
Untangling the Tauopathy for Alzheimer’s disease and parkinsonism
Chang, H.-Y., Sang, T., & Chiang, A. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0457-x · Cited by 56
Autophagy-Mediated Secretory Pathway is Responsible for Both Normal and Pathological Tau in Neurons
Kang, S., Son, S. M., Baik, S. H., Yang, J., & Mook‐Jung, I. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190180 · Cited by 52
Molecular Tools to Detect Alloforms of Aβ and Tau: Implications for Multiplexing and Multimodal Diagnosis of Alzheimer’s Disease
Arora, H., Ramesh, M., Rajasekhar, K., & Govindaraju, T. (2020) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.20190356 · Cited by 53
Different inhibitory response of cyanidin and methylene blue for filament formation of tau microtubule-binding domain
Hattori, M., Sugino, E., Minoura, K., In, Y., Sumida, M., Taniguchi, T., Tomoo, K., & Ishida, T. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.001 · Cited by 53
Prefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disorders
Kayed, R., & Jackson, G. R. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.001 · Cited by 56
Functional Characterization of FTDP-17 tau Gene Mutations through Their Effects on Xenopus Oocyte Maturation
Delobel, P., Flament, S., Hamdane, M., Jakes, R., Rousseau, A., Delacourte, A., Vilain, J., Goedert, M., & Buée, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107716200 · Cited by 53
Self-citation
Tauists, Baptists, Syners, Apostates, and new data
Trojanowski, J. Q. (2002) · Annals of Neurology · doi:10.1002/ana.10281 · Cited by 53
Self-citation
The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers
Martínez, M. F., Martín, X. E., Alcelay, L. G., Flores, J. C., Valiente, J., Juanbeltz, B. I., Gómez‐Beldarrain, M. Á., López, J. M., González-Fernández, M. C., Salazar, A. M., et al. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-125 · Cited by 52
Type-Dependent Oxidative Damage in Frontotemporal Lobar Degeneration: Cortical Astrocytes Are Targets of Oxidative Damage
Martínez, A., Carmona, M., Portero‐Otín, M., Naudí, A., Pamplona, R., & Ferrer, I. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818e06f3 · Cited by 53
High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-β and tau pathologies in the 3xTg-AD model of Alzheimer's disease
Phivilay, A., Julien, C., Tremblay, C., Berthiaume, L., Julien, P., Giguère, Y., & Calon, F. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.12.006 · Cited by 55
Clinico-Pathological Correlations of the Most Common Neurodegenerative Dementias
Taipa, R. J. F., Pinho, J., & Pires, M. M. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00068 · Cited by 54
Inhibition of tau aggregation using a naturally-occurring cyclic peptide scaffold
Wang, C. K. L., Northfield, S. E., Huang, Y., Ramos, M. C., & Craik, D. J. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.01.006 · Cited by 52
Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau
Strang, K. H., Goodwin, M. S., Riffe, C. J., Moore, B. D., Chakrabarty, P., Levites, Y., Golde, T. E., & Giasson, B. I. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0458-0 · Cited by 53
Highly specific and selective anti‐pS396‐tau antibody C10.2 targets seeding‐competent tau
Rosenqvist, N., Asuni, A. A., Andersson, C. R., Christensen, S., Daechsel, J. C. A., Egebjerg, J., Falsig, J., Helboe, L., Jul, P., Kartberg, F., et al. (2018) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.09.005 · Cited by 52
Overview of Protein Aggregation in Single, Double, and Triple Neurodegenerative Brain Amyloidoses
Trojanowski, J. Q., & Mattson, M. P. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:4:1-2:1 · Cited by 53
Self-citation
Atypical dementia associated with a novel presenilin‐2 mutation
Binetti, G. G., Signorini, S. G., Squitti, R., Alberici, A., Benussi, L., Cassetta, E., Frisoni, G. B., Barbiero, L., Feudatari, E., Nicosia, F. M., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10760 · Cited by 52
Stress kinases involved inTau phosphorylation in alzheimer’s disease, tauopathies and APP transgenic mice
Ferrer, I. (2004) · Neurotoxicity Research · doi:10.1007/bf03033283 · Cited by 53
Genetics of the dementias
Schott, J. M. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.suppl_2.ii27 · Cited by 51
Neurodegenerative processes accelerated by protein malnutrition and decelerated by essential amino acids in a tauopathy mouse model
Sato, H., Takado, Y., Toyoda, S., Tsukamoto‐Yasui, M., Minatohara, K., Takuwa, H., Urushihata, T., Takahashi, M., Shimojo, M., Ono, M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd5046 · Cited by 51
Tau Aggregation
Hernández, F., Ferrer, I., Pérez, M., Zabala, J. C., del Rı́o, J. A., & Ávila, J. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.04.024 · Cited by 49
Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception
Moda, F., Ciullini, A., Dellarole, I. L., Lombardo, A., Campanella, N., Bufano, G., Cazzaniga, F. A., & Giaccone, G. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2810255 · Cited by 49
Binding cavities and druggability of intrinsically disordered proteins
Zhang, Y., Cao, H., & Liu, Z. (2015) · Protein Science · doi:10.1002/pro.2641 · Cited by 51
Inhibition of the canonical Wnt pathway by Dickkopf-1 contributes to the neurodegeneration in 6-OHDA-lesioned rats
Dun, Y., Li, G., Yang, Y., Xiong, Z., Feng, M., Wang, M., Zhang, Y., Xiang, J., & Ma, R. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.07.030 · Cited by 51
Deficiency of the zinc finger protein ZPR1 causes neurodegeneration
Doran, B., Gherbesi, N., Hendricks, G. M., Flavell, R. A., Davis, R. J., & Gangwani, L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602057103 · Cited by 51
Mutation in Archain 1, a Subunit of COPI Coatomer Complex, Causes Diluted Coat Color and Purkinje Cell Degeneration
Xu, X., Kedlaya, R., Higuchi, H., Ikeda, S., Justice, M. J., Setaluri, V., & Ikeda, A. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000956 · Cited by 51
Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology
Song, L., Lu, S. X., Ouyang, X., Melchor, J. P., Lee, J., Terracina, G., Wang, X., Hyde, L. A., Hess, J. F., Parker, E. M., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0011-1 · Cited by 51
Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy
Makani, V. S., Zhang, B., Han, H., Yao, Y., Lassalas, P., Lou, K., Paterson, I., Lee, V. M. ‐., Trojanowski, J. Q., Ballatore, C., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0378-4 · Cited by 52
Self-citation
Development of a BODIPY-based fluorescent probe for imaging pathological tau aggregates in live cells
Lim, S., Haque, M. M., Su, D., Kim, D., Lee, J., Chang, Y., & Kim, Y. K. (2017) · Chemical Communications · doi:10.1039/c6cc08826k · Cited by 51
Short-term exposure to dim light at night disrupts rhythmic behaviors and causes neurodegeneration in fly models of tauopathy and Alzheimer's disease
Kim, M., Subramanian, M., Cho, Y.-H., Kim, G.-H., Lee, E., & Park, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.021 · Cited by 51
Determination of protein phosphorylation by polyacrylamide gel electrophoresis
Lee, C., Park, Y., Min, H., Kim, Y.-R., & Seok, Y. (2019) · The Journal of Microbiology · doi:10.1007/s12275-019-9021-y · Cited by 51
Four-Repeat Tauopathies: Current Management and Future Treatments
VandeVrede, L. A., Ljubenkov, P. A., Rojas, J. C., Welch, A. E., & Boxer, A. L. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00888-5 · Cited by 55
Selective reduction of soluble Tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study
Zhukareva, V. A., Sundarraj, S., Mann, D. M. A., Sjögren, M. J. C., Blenow, K., Clark, C. M., McKeel, D. W., Goate, A., Lippa, C. F., Vonsattel, J., et al. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0668-8 · Cited by 51
Self-citation
Working memory impairment in a transgenic amyloid precursor protein TgCRND8 mouse model of Alzheimer's disease
Lovasic, L., Bauschke, H. H., & Janus, C. (2004) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2004.00104.x · Cited by 53
Mutant (R406W) Human Tau Is Hyperphosphorylated and Does Not Efficiently Bind Microtubules in a Neuronal Cortical Cell Model
Krishnamurthy, P., & Johnson, G. V. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311203200 · Cited by 51
Antibody Therapeutics Targeting Aβ and TauPreprint
Gallardo, G., & Holtzman, D. M. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024331 · Cited by 55
Topical ocular administration of the GLP-1 receptor agonist liraglutide arrests hyperphosphorylated tau-triggered diabetic retinal neurodegeneration via activation of GLP-1R/Akt/GSK3β signaling
Shu, X., Zhang, Y., Li, M., Huang, X., Yang, Y., Zeng, J., Zhao, Y., Wang, X., Zhang, W., & Ying, Y. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.04.018 · Cited by 51
Transition metal nickel prevents Tau aggregation in Alzheimer's disease
Gorantla, N. V., Das, R., Balaraman, E., & Chinnathambi, S. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.11.176 · Cited by 50
Tau and Alpha Synuclein Synergistic Effect in Neurodegenerative Diseases: When the Periphery Is the Core
Vacchi, E., Kaelin‐Lang, A., & Melli, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145030 · Cited by 51
Tau induces inflammasome activation and microgliosis through acetylating NLRP3
Zhang, L., Gai, Y., Liu, Y., Meng, D., Zeng, Y., Luo, Y., Zhang, H., Wang, Z., Yang, M., Li, Y., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1623 · Cited by 52
Possible Role of Resveratrol Targeting Estradiol and Neprilysin Pathways in Lipopolysaccharide Model of Alzheimer Disease
Sayed, N. S. E., & Bayan, Y. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-08927-0_12 · Cited by 52
Discovery of Brain-Penetrant, Orally Bioavailable Aminothienopyridazine Inhibitors of Tau Aggregation
Ballatore, C., Brunden, K. R., Piscitelli, F., James, M. J., Crowe, A., Yao, Y., Hyde, E. G., Trojanowski, J. Q., Lee, V. M. ‐., & Smith, A. B. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100138f · Cited by 52
Self-citation
Alzheimer's Therapeutics: Translation of Preclinical Science to Clinical Drug Development
Savonenko, A. V., Melnikova, T., Hiatt, A., Li, T., Worley, P. F., Troncoso, J. C., Wong, P. C., & Price, D. L. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.211 · Cited by 52
Pseudohyperphosphorylation Causing AD-like Changes in Tau Has Significant Effects on Its Polymerization
Sun, Q., & Gamblin, T. C. (2009) · Biochemistry · doi:10.1021/bi900602h · Cited by 54
FUS-mediated alternative splicing in the nervous system: consequences for ALS and FTLD
Orozco, D., & Edbauer, D. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1077-2 · Cited by 52
The G389R mutation in the MAPT gene presenting as sporadic corticobasal syndrome
Rossi, G., Marelli, C., Farina, L., Laurá, M., Basile, A. M., Ciano, C., Tagliavini, F., & Pareyson, D. (2008) · Movement Disorders · doi:10.1002/mds.21970 · Cited by 50
Single Posttranslational Modifications in the Central Repeat Domains of Tau4 Impact its Aggregation and Tubulin Binding
Ellmer, D., Brehs, M., Haj‐Yahya, M., Lashuel, H. A., & Becker, C. F. W. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201805238 · Cited by 49
Right temporal variant frontotemporal dementia is pathologically heterogeneous: a case-series and a systematic review
Ulugut, H., Dijkstra, A. A., Scarioni, M., Bank, N. B., Barkhof, F., Scheltens, P., Rozemüller, A. J. M., & Pijnenburg, Y. A. L. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01229-z · Cited by 51
RETRACTED: Wild type and P301L mutant Tau promote neuro-inflammation and α-Synuclein accumulation in lentiviral gene delivery models
Khandelwal, P. J., Dumanis, S. B., Herman, A. M., Rebeck, G. W., & Moussa, C. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.09.002 · Cited by 52
Retracted
Gene structure and alternative splicing of glycogen synthase kinase 3 beta (GSK-3β) in neural and non-neural tissues
Schaffer, B., Wiedau‐Pazos, M., & Geschwind, D. H. (2003) · Gene · doi:10.1016/s0378-1119(02)01092-2 · Cited by 50
A Review and Rationale for the Use of Genetically Engineered Animals in the Study of Traumatic Brain Injury
Longhi, L. G., Saatman, K. E., Raghupathi, R., Laurer, H. L., Lenzlinger, P. M., Riess, P., Neugebauer, E. A. M., Trojanowski, J. Q., Lee, V. M. ‐., Grady, M. S., et al. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200111000-00001 · Cited by 51
Self-citation
Different associational and conformational behaviors between the second and third repeat fragments in the tau microtubule‐binding domain
Minoura, K., Yao, T., Tomoo, K., Sumida, M., Sasaki, M., Taniguchi, T., & Ishida, T. (2004) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03956.x · Cited by 50
Presenilins in synaptic function and disease.
Ho, A., & Shen, J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.06.002 · Cited by 52
Tau-Directed Immunotherapy: A Promising Strategy for Treating Alzheimer’s Disease and Other Tauopathies
Schroeder, S. K., Joly‐Amado, A., Gordon, M. N., & Morgan, D. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9637-6 · Cited by 51
Machine learning prediction and tau-based screening identifies potential Alzheimer’s disease genes relevant to immunity
Binder, J., Ursu, O., Bologa, C., Jiang, S., Maphis, N., Dadras, S., Chisholm, D., Weick, J., Myers, O., Kumar, P., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03068-7 · Cited by 49
Zinc enhances liquid-liquid phase separation of Tau protein and aggravates mitochondrial damages in cells
Gao, Y., Zhong, T., Wang, L., Zhang, N., Zeng, Y., Hu, J.-Y., Dang, H.-B., Chen, J., & Liang, Y. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.04.034 · Cited by 48
The evolving landscape of Alzheimer’s disease therapy: From Aβ to tau
Courade, J., Zetterberg, H., Höglinger, G. U., & Dewachter, I. (2025) · Cell · doi:10.1016/j.cell.2025.11.033 · Cited by 57
Visualizing Pathology Deposits in the Living Brain of Patients with Alzheimer's Disease
Kepe, V., Huang, S., Small, G. W., Satyamurthy, N., & Barrio, J. R. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)12010-8 · Cited by 49
Design of an orally efficacious hydroxyethylamine (HEA) BACE-1 inhibitor in a preclinical animal model.
Truong, A. P., Tóth, G., Probst, G., Sealy, J., Bowers, S., Wone, D. W. G., Dressen, D., Hom, R. K., Konradi, A., Sham, H., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.102 · Cited by 49
Inflammatory Eicosanoids Increase Amyloid Precursor Protein Expression via Activation of Multiple Neuronal Receptors
Herbst, K. J., Liu, L., James, M., Yao, Y., Xie, S. X., & Brunden, K. R. (2015) · Scientific Reports · doi:10.1038/srep18286 · Cited by 50

Authors: Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q.
Affiliations: MRC Laboratory of Molecular Biology (GB)
ORCID: Lee, Virginia M-Y
Goedert, Michel
Trojanowski, John Q
Venue: Annual Review of Neuroscience
Publisher: Annual Reviews
Published: 2001-03
Volume: 24
Issue: 1
Pages: 1121-1159
ISSN: 0147-006X (ISSN-L)
1545-4126
DOI: 10.1146/annurev.neuro.24.1.1121
OpenAlex: W4230565756
Semantic Scholar: 8eb6355272daf41b8da72a5b18a4d8c67d8509cc
Cited by: 2,480
References: 245
Citations by year: 2026: 60 · 2025: 81 · 2024: 102 · 2023: 112 · 2022: 133 · 2021: 130 · 2020: 126 · 2019: 107 · 2018: 114 · 2017: 94 · 2016: 100 · 2015: 115 · 2014: 99 · 2013: 100 · 2012: 92
FWCI: 9.22
Type: journal article
Language: en
Open access: closed
Locations: Annual Review of Neuroscience (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords: tau protein, tau gene mutations, FTDP-17, progressive supranuclear palsy, corticobasal degeneration, Pick's disease, Alzheimer's disease, tau fibrillization, genetic risk factors, transgenic animal models, neurodegeneration
MeSH terms: Animals, Brain, Brain Diseases, Dementia, Humans, Neurofibrillary Tangles, tau Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neurodegenerative Tauopathies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks